LONDON, UK Sun European Partners, LLP (“Sun European Partners”), the European adviser to Sun Capital Partners, Inc., announces that one of its affiliates has completed the acquisition of NextPharma Technologies Holding Ltd. (“NextPharma”), a global provider of contract manufacturing, product development, clinical trials and logistics services to the pharmaceutical and biotechnology industry. Terms of the transaction were not disclosed.
Headquartered in Surrey, UK, NextPharma offers a range of services spanning the entire drug development, manufacturing and distribution supply chain. The company is a leading outsourcing partner to the pharmaceutical, biotech and healthcare industries with seven manufacturing facilities, seven product development centres and six temperature–controlled storage and distribution sites across Europe and the U.S.. NextPharma supports more than 200 customers including leading blue chip pharmaceutical and biotech companies.
Bill Wedlake, CEO of NextPharma commented: “The integrated outsourcing model offered by NextPharma helps improve client profitability by reducing both the cost and time to market of the product. This service increases client margins by reducing the number of supply chain providers and freeing up client resource to concentrate on their own key strategic strengths of research and marketing. We look forward to working with Sun European Partners to continue to grow the company and to expand into innovative new technologies and markets.”
Matthias Gundlach, Vice President of Sun European Partners said: “We are delighted by this acquisition. NextPharma is well positioned to benefit from the changing face of the drug industry, in particular using drug development and manufacturing outsourcing. It provides a good foundation from which to build the business organically and by acquisitions.”
About Sun European Partners, LLP
Sun European Partners, LLP is the European adviser to Sun Capital Partners, Inc., a leading U.S.–based private investment firm focused on leveraged buyouts, equity, debt, and other investments in market–leading companies that can benefit from its in– house operating professionals and experience. Affiliates of Sun Capital Partners, Inc. have invested in 260 companies worldwide with combined sales in excess of $40 billion since the inception of Sun Capital Partners, Inc. in the U.S. in 1995. Sun Capital Partners, Inc. has offices in Boca Raton, Los Angeles, and New York, as well as affiliates with offices in London, Frankfurt, Paris, Luxembourg, Shanghai and Shenzhen. For more information, please visit www.SunEuropeanPartners.com.
